Business Context and Reporting Period
This Form 8-K Current Report was filed by Bionexus Gene Lab Corp on October 15, 2019, covering events occurring on October 1, 2019. The company is incorporated in Wyoming and identifies as an emerging growth company. The principal executive offices are located in Kuala Lumpur, Malaysia.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on a material definitive agreement regarding equity grants.
Material Changes
The primary material change reported is the entry into Stock Grant Agreements with four key officers on October 1, 2019. This transaction resulted in a significant increase in the company's outstanding share count:
- Prior Outstanding Shares: 74,627,558
- Shares Issued via Grant: 17,000,000
- New Outstanding Shares: 91,627,558
The grants were distributed as follows:
- Soo Kow Lai (Chairman): 5,000,000 shares
- Chi Yuen Leong (President): 5,000,000 shares
- Chan Chong Wong (CEO): 5,000,000 shares
- Wei Li Leong (CFO): 2,000,000 shares
Terms, Risks, and Contingencies
Vesting and Clawback Provisions: While the granted shares vest immediately, they are subject to clawback rights. Officers must forfeit and repay the shares (or proceeds from their sale) if a majority of the Board determines a "Cause Event" occurred between the grant date and September 30, 2022.
Definition of Cause Event: Includes acts of disloyalty, gross negligence, willful misconduct, dishonesty, fraud, and willful disparagement of the Company.
Beneficial Ownership Impact: Following the grants, the four executive officers and directors collectively beneficially own 47,000,000 shares, representing 51.29% of the outstanding common stock. Dr. Choong-Chin Liew remains a significant shareholder with 21.83% ownership.
Investor Verification Checklist
- Verify the fair market value of the 17,000,000 shares granted to assess potential dilution impact.
- Review the full text of the Stock Grant Agreements (Exhibit 10.4) for specific definitions of "Cause Event" and repayment mechanics.
- Confirm the company's current cash position to ensure it can sustain operations despite the lack of reported revenue in this filing.
- Monitor the concentration of ownership, as insiders now control over 51% of the voting power.